Fernanda Vaisman

Universidade Federal do Rio de Janeiro — Brazil

Medicine · Health Sciences

27h-index3.1kcitations109works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(91), Thyroid and Parathyroid Surgery(21), Thyroid Disorders and Treatments(18), BRCA gene mutations in cancer(16), Head and Neck Anomalies(11)

Publications109 total

Response to the letter to the editor: Appraisal of suspicious for malignancy cytology: nuclear characteristics deserve special attention in reported cytology analysis – real-world scenario cohort in thyroidology
Archives of Endocrinology and Metabolism·2026Open Access
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in <i>RET</i> -Mutant Medullary Thyroid Cancer
Thyroid·2025· 2 citedOpen Access
Changing Surgical Paradigms for Medullary Thyroid Cancer: From “One Size Fits All” to An Individualized Approach Based on Calcitonin and Desmoplasia
Clinical Thyroidology·2025
Adequate Management and Control of Hyperthyroidism Is Crucial for Graves' Orbitopathy, but the Best Way To Do It… Still Controversial
Clinical Thyroidology·2025
Does Radioactive Iodine Therapy Change Outcomes in All Low-to-Intermediate Risk N1b Papillary Thyroid Cancers?
Clinical Thyroidology·2025
Genetic or familiar forms of primary hyperparathyroidism: description of a case series with familial isolated hyperparathyroidism and review of the literature
Archives of Endocrinology and Metabolism·2025Open Access
The extent of extranodal extension as a prognostic indicator in papillary thyroid cancer
Archives of Endocrinology and Metabolism·2025Open Access
In suspicious for malignancy thyroid nodule aspirates, nuclei characteristics deserves special attention in reported cytology analysis – real world scenario cohort
Archives of Endocrinology and Metabolism·2025· 1 citedOpen Access
Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?
Endocrine·2024· 1 cited
Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC).
Journal of Clinical Oncology·2024· 3 cited
External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long‐term local disease control?
Head & Neck·2024· 2 cited
Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients
Endocrine·2024· 3 cited
Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer
European Thyroid Journal·2024· 2 citedOpen Access
Brazilian Consensus on the Application of Thermal Ablation for Treatment of Thyroid Nodules: A Task Force Statement by the Brazilian Society of Interventional Radiology and Endovascular Surgery (SOBRICE), Brazilian Society of Head and Neck Surgery (SBCCP), and Brazilian Society of Endocrinology and Metabolism (SBEM)
Archives of Endocrinology and Metabolism·2024· 8 citedOpen Access
Response to the letter to the editor: Thyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)
Archives of Endocrinology and Metabolism·2024Open Access
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America
Archives of Endocrinology and Metabolism·2024· 4 citedOpen Access
Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates
Archives of Endocrinology and Metabolism·2024· 1 citedOpen Access
Physicians’ preferencesfor radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study
Archives of Endocrinology and Metabolism·2024Open Access
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
Thyroid·2023· 14 citedOpen Access
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
Reviews in Endocrine and Metabolic Disorders·2023· 7 cited
page 1 of 6Next →

Frequent Co-authors

Rossana Corbo(29), Mário Vaisman(26), Daniel Bulzico(15), Denise Momesso(13), R. Michael Tuttle(10), Fernanda Accioly de Andrade(6), Cencita H. C. N. Pessoa(5), Fernando Luiz Dias(5), Ana O. Hoff(5), Hans Graf(5), Ashok R. Shaha(4), Paulo Alonso Garcia Alves(4), Cláudia Medina Coeli(4), Laura Sterian Ward(4), Gisah Amaral de Carvalho(4), Daniel Barretto Kendler(4), Ian Ganly(3), Marcia S. Brose(3), Steven I. Sherman(3), Jolanta Krajewska(3)